Human cells build protein cages to trap invading Shigella
Pascale Cossart, Ph.D., and Serge Mostowy, Ph.D., reported that the septin cages not only targeted the pathogens for degradation by autophagy, the cell's internal garbage disposal system, but also prevented the Shigella bacteria from spreading to other cells by impeding the pathogens' access to actin, a different component of the cell skeleton.
Shigella requires actin to rocket around the host cell before punching into an adjacent cell, said the Pasteur researchers, who made their discovery in human cells grown in culture in the laboratory.
First discovered in yeast as rings that pinch off dividing cells, septins are Guanosine-5'-triphosphate (GTP)-binding proteins that are integral to a cell's dynamic skeleton. Cossart, a Howard Hughes Medical Institute (HHMI) investigator, and Mostowy continue to investigate the properties of the individual septins, which total 14 in humans, to understand how they associate with other proteins as parts of complex nano-machines.
Before their studies revealed septin's new role in innate immunity, Cossart and Mostowy said that the cytoskeletal protein already was implicated in the pathogenesis of many human disorders including leukemia and colon cancer as well as Parkinson's and Alzheimer's diseases.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.